Category Archives: Community

Notes from the North – Happy Mother’s Day!

Anyone who has been to the supermarket or drug store in the last couple of weeks has been bombarded with commercial reminders that mother’s day is just around the corner. Flowers, mom mugs, and cards all vie for attention next to registers beckoning shoppers to make a purchase and check mother’s day responsibility off the to-do list. When I picked up a tea kettle printed with spring flowers for my own mother, I was thinking of it as a mechanism to express my gratitude for all the love and support she has lavished on me. Having recently produced my own offspring, however, I find myself reflecting on the truly amazing biological processes that must occur in order for us to be here to celebrate mother’s day. So in addition to thanking her for being the amazing person she is, I also thank her for embarking on an amazing biological adventure three decades ago.

The grind of assays, meetings, and deadlines often forces us to narrow our focus exclusively on our own little piece of the biological puzzle such that thinking about the larger pattern becomes overwhelming. This weekend I will be trying to contemplate the biology of motherhood with wonder and appreciation instead of my more typical bewilderment.

As med-bio researchers we are more attuned than most to the incredible number of steps that must take place in near perfect choreography for a healthy living organism to result. Dividing cells talk and cross-talk, differentiate at variable rates, and form functioning organs that allow the growing fetus to become more and more independent. For mammals, cross talk between the maternal system and the fetal system trigger additional developmental programs for lactation in mom that were arrested at puberty.  In the hood we are happy if we can get our cultures to remain viable for more than several months. With all the resources of a full organism, cells can still be fully functional decades later without resorting to preservation in liquid nitrogen!

Incidentally, there was a student at Stanford a few years back who was also moved by mother’s day to contemplate the science behind the celebration. He expressed his appreciation much more eloquently than I in a ballad that can be found here on YouTube.

This mother’s day take time to celebrate the positive impact your mother has had in your life and use it also as a day to celebrate eons of evolution that result in modern biology. And don’t forget father’s day and grandparent’s day too!

Introducing SPINES

As scientists who come from underrepresented backgrounds, we have had many informal discussions about the climate at Sackler and advocating for diversity in the graduate programs at Sackler. While Tufts Sackler supports various pipeline initiatives (PREP, P2P, BDBS) we feel that it does not have mechanisms in place that intentionally create a space for minority scientists who are training at Sacker. We met in March and had an open discussion about our interests relevant to the group, the immediate needs of the community, and long term goals.

Mission:
Programs aimed at diversifying the STEM academy have successfully increased recruitment of undergraduate and graduate students from groups traditionally underrepresented in careers in the sciences. An emphasis on recruitment may help to update the narrow image of what a scientist looks like, but additional action is needed to evolve the full picture of who scientists are. We are Scientists Promoting INclusive Excellence at Sackler (SPINES).

Inclusive excellence is a model first proposed by the American Academy for Colleges and Universities and recognizes that efforts of diversity can result in meaningful, measurable improvements in the excellence of an institution when that institution creates an environment that welcomes the cultural diversity of those included. For the STEM academy to benefit from a diversity of contributors, the culture and atmosphere of the STEM academy must update to include that of the new participants. It is this dissonance that may be responsible for the ever discussed “leaky pipeline” or disappearance of diverse bodies from the STEM career path as their career trajectory progresses. As problematic as the “pipeline” analogy is (we can unpack that for days), anyone concerned with progress in the sciences should recognize that this progress requires sustained conversations around social justice issues and retention of minority scientists.

SPINES believes we can help each other achieve inclusive excellence in the sciences by building a community of scientists at Sackler who recognize and celebrate each other’s diversity of ability, ethnicity, sexual orientation, religious affiliation and gender identity. We formally describe our mission below, but loosely we want to build spaces where we feel free to discuss all aspects of our lives as developing scientists. We will offer each other support even if this means giving technical advice as someone works through frustrating equipment errors in the lab or offering a shoulder to lean on as one struggles with the pain and helpless feeling from viewing the latest videotaped example of injustice on the nightly news.

Below we list some short-term goals for the group; however, we would like to highlight that our organizational model relies on horizontal leadership and community-based decision-making. We recognize that the needs and priorities of a community can change over time and therefore we encourage all members to take active roles in developing and implementing their ideas with the knowledge that the entire group will support them.

Short-term goals
• Enhance the diversity of speakers that are invited to give program seminar talks
• Learn about active bystander, anti-oppression, intersectionality, and privilege via reading books, articles, and invited  speakers
• Connect incoming underrepresented graduate students with a peer mentor
• Build professional connections with biotech/industry to address the lack of diversity in these sectors
• Provide networking opportunities

Our priority is to establish a welcoming community at Sackler where people of all backgrounds and identities feel nurtured and supported in achieving their scientific, personal, and intellectual goals.

Look out for our upcoming events and for more information see: https://tuftsspines.wixsite.com/tuftsspines

Written by: Camila Barrios-Camacho, Chris Bartolome, Janel Cabrera, Laverne Melón, and Vanessa Yanez

Humans of Sackler: Patrick Davis, “I’ve been Accused of being a Science Robot”

Humans of Sackler, 23 March 2017

Patrick Davis, Neuroscience, Fifth-Year M.D./Ph.D. Student: “I’ve been Accused of being a Science Robot”

For this issue of Humans of Sackler, I had the opportunity to sit down with Patrick Davis, an M.D./Ph.D. student in the Neuroscience program. Although I see medical students coming and going around Sackler every day, I confess I haven’t gotten to know many of them – or much at all about the medical school curriculum. So it was a great pleasure to learn more about this from somebody who is as passionate about medicine as he is about science research; Patrick and I had a particularly engrossing conversation about the differences between these two kinds of higher education, and I hope you, dear reader, enjoy and benefit from it as much as I did!

 

Young Pat with the Chestnut Hill Academy Theoretical Physics Group

AH: How did you become interested in studying science?

PD: I had a physics teacher in 11th and 12th grade – Marty Baumberger – who was just the best teacher ever. He got me so into physics that I started a Theoretical Physics group at Chestnut Hill Academy… I went to Brown University as a physics major. I loved the open curriculum, but I was a terrible student. I didn’t do well my first year, so I switched to an economics major for about a year, and that was completely unfulfilling. Eventually I came to my senses and switched to biology… The thing about Brown: it’s chaos. There are no required classes, so you just mix and match and do whatever. There are requirements for your major, but you could theoretically never take a math class if you never wanted to. What happened to me was the best-case scenario: the first year and a half made me a more dedicated student. I learned that if I’m not doing something I really want to do then I’m going to be lazy, and if I don’t work hard then I’m not going to do well.

 

At a Macklis Lab get-together, chatting with friend and mentor Alex Poulopoulos (left)

AH: What was your first experience with neuroscience research?

PD: When I graduated from Brown, I didn’t know right away that I wanted to do med school or neuroscience. I ended up working at Jeff Macklis’s lab at Mass General Hospital for two years after college, and that was my first real exposure to neuroscience. Jeff made his name with a series of studies on induction of neurogenesis in the neocortex. I met Alex Poulopoulos there, who has been a mentor ever since, and a very good friend. I would credit Alex almost entirely with piquing my interest in neuroscience, but also with my development as a scientist. I love to come up with an idea, test it, go through the whole process myself, interpret my own data, talk to other people about their data – I like the actual scientific process. Alex just started his own lab at University of Maryland School of Medicine; anybody reading this, please apply to his lab! You could not ask for a better person to work for. He’s interested in how neural circuits self-organize, which is extremely interesting to me as well.

 

With pals from Brown University

AH: Why did you choose the M.D./Ph.D. path and how have your medical and scientific training differed?

PD: I could never be just an M.D. because I love science too much. The fundamental quality of a scientist is curiosity; medicine is more like service and helping people, curiosity about the people themselves, empathy. The preclinical years are a lot of memorization, but once you get into the hospital, it’s more like an apprenticeship. You’re learning how to do the day-to-day things that a doctor does: how to walk through clinical decision-making, interview a patient, present that information to other doctors, how to work with your hands if you’re doing a surgery rotation… Because medicine is an applied science, the goal there is all oriented around the health of the patient; I don’t think that’s really what science is about. For a long time, medicine has been done in a very parochial way: people in this hospital do it this way, people in another hospital do it another way. Evidence-based medicine still gets a lot of pushback. Take stenting for example: doing a coronary artery stent for someone with angina. About half of the stents in this country are done for stable angina – chest pain when you exercise, but not an acute threat to your health – and it’s now been shown over and over again that that is no better, and possibly worse, than just giving them statins and blood pressure reduction medication and telling them to eat their vegetables and exercise a little bit. It’s because doctors think in terms of, ‘I see it happen, it intuitively makes a lot more sense to me, so it must be this.’ Of course the lines are blurred in real life, but a true scientist would say, ‘We have to trust the evidence, why don’t we look at what’s causing the increased risk of doing the stent, or why do statins work?’ The curiosity that is absolutely necessary to be a good scientist is not necessary to be a good doctor… The types of mind that are selected for by these two professions are almost non-overlapping, they’re completely different.

 

Even science robots enjoy a night on the town every now and then

AH: What do you like to do when you’re not studying medicine or neuroscience, and how do you find the time and energy to do it all?

PD: I love to teach, I really like being in the didactic role and seeing people learn and discover things for themselves. I tutor for the MCAT, I used to tutor for the SAT, I’ve volunteered for things like middle school science fair mentoring and the Brain Bee. These kids in the Brain Bee were extremely impressive; they knew more facts for this test than I would have! Thomas Papouin and I also started a class trying to teach grad students the basics of the scientific method. There’s a whole rich history of how to think formally and scientifically; and the more aware you are of it and the more you practice it – like by applying these things to your own rotation project or qualifying exam – the better you get at it. The notion that, by just reading papers, this will happen – for some people, maybe it will, but the purpose of the program is to maximize the probability of this happening for everybody… I’ve been accused of being a science robot: the joke between Alex Jones and me is that when I get home, I have a scotch and read PubMed… The M.D./Ph.D.s that I’ve spoken to, the ones that succeed, are recharging one half of their brain while the other one works. Like a shark, like a science shark!

 

Relaxing by a picturesque mountain lake in the Cordillera Blanca, Peru

AH: Have you had many chances to travel outside of the U.S.?

PD: I’ve traveled through Europe a bit, I’ve been to Peru, Brazil… I was in Berlin at one point, and I decided to just hop on a train and go to Prague. I spent two full days and a night there, and it was awesome. Most of the people spoke English at tourist-type places, but it was fun to walk around, take pictures, be completely by myself… I had a Cormac McCarthy book called “All the Pretty Horses”, and it was nice just being on the train, reading or watching the sites, then walking around the city and going to a café for a coffee or beer. I don’t know much else about Prague, but aesthetically, I can’t imagine a prettier city. Part of why I enjoyed the city so much was because I didn’t expect it to be that way: of course when you go to Rome, you know that one of the greatest civilizations existed here and that every step you take is rich with history, but I didn’t expect this in Prague.

 

Enthusiastically sharing data at the Society for Neuroscience annual meeting

AH: What topic have you studied for your thesis work?

PD: Under Leon Reijmers’ mentorship, I’m trying to figure out how ‘extinction learning’ happens in the brain: it’s a medically-relevant type of learning that underlies treatment for psychiatric disorders like PTSD. In extinction learning, the patient repeatedly gets exposed to the thing they’re afraid of, you gradually increase the ‘stimulus intensity’, and they learn that it’s safe. So for example, if they’re afraid of spiders, you would show them a picture of a spider at first, then maybe have them in a room where there’s a spider in a corner, then work your way up to having them handle a spider. What I’ve found is that there’s a particular cell type in the amygdala – the parvalbumin interneuron – which acts a critical hub for this kind of learning: if you silence these cells, then you shut down the process of extinction learning. Now I’m using that finding as a jumping-off point to really figure out what’s going on. I’m manipulating parvalbumin interneurons with different frequencies of stimulation and seeing how the amygdala – and the rest of the brain – responds to that. It looks like I can ‘toggle’ the fear state up or down just by controlling this specific type of neuron!

 

Contemplating the mysteries of the universe

AH: Where do you see the field of neuroscience heading in the near future?

PD: I think that we have tools in neuroscience that 15 years ago, you couldn’t have even fathomed. Not just optogenetics, but recording techniques, chemogenetics, optical electrophysiology, simultaneous local field potentials with single units, closed loop systems… The engineers like Ed Boyden have done us a great favor. But now it’s time for us to step up. I think that in the next 2, 5, 10, 15 years there are going to be many, many discoveries that are really going to blow things open. Once we fall out of love with the mere application of modern tools to hypotheses we already kind of assumed to be true, then we’re going to ask the question: how? You have to record neurons’ endogenous activity, then do experiments that are really informative about what’s going on. In neuroscience, because we have these techniques, we can start asking this kind of question.

A guide to making effective protest signs

With the first ever March for Science two weeks away, a lot of us are sitting and scratching our heads thinking up the perfect rhyme, or the perfect punchline to write on cardboard that would express our outrage or our incredulity against proposed cuts for the NIH, or our passion for our favorite scientific topic, or even why science is awesome and important. We have so much to say, except there is only so much space on the cardboard or even the banner. Given that brevity is the mother of wit, we believe that you can come up with awesome signs for the March by yourself. However, we just wanted to provide some tips to help you along the way! If you happen to make a sign similar to someone else, don’t lose heart. Repetition = reinforcement, so it will show your solidarity with others. 

1. Use literary devices – Parallelism is a great way to get your message across and make it memorable. If you can make it rhyme, even better since it can turn your message into a chant! As the linguist Daniel Midgley describes, both parallelism and rhyming make slogans readable and memorable. In addition to rhyming, clever usage of common memes will also help making your sign memorable, such as the one below. 

Source: L May/Twitter

2. Be Positive – While the proposed cuts to the NIH budget may not sound funny at all and the future of scientific research looks bleak under this administration, negativity will not help win supporters. Instead, spin your negativism into a humorous catch-phrase that either expresses your incredulity (eg – “OMG GOP WTF”) or your positive attitude (eg – “We Are Better Than This”). 

3. Use Symbols – Your message can be personal and defined based on what you want to say, but  you can still express your solidarity with the overall cause by including the symbols of the protest (eg – the Boston March for Science has incorporated the official logo of the March for Science with its own twist by adding the Zakim bridge over it).

Official March for Science logo
Boston March for Science logo

4.  Focus on the Issues – Emotional reactions to President Trump and his proposed changes are inevitable. However, given that he has been in office for 3 months, it would not help to make signs that say “Not My President”. Instead, make sure your signs reflect the issues at hand – climate change, funding for scientific research, evidence-based policymaking, etc. Your sign should tell the rest of us about the cause you support in the specific context rather than a knee-jerk reaction, which may be valid but out of context. So, be informed about the specific goals of the march, and use those points to shape your message. 

5. Don’t be Partisan – Remember, it’s a non-partisan march, but it is not apolitical. Both democrats and republicans have utilized science as a tool to make political gains. However, this march is beyond petty partisan politics. This is something much more fundamental – it is about the defense of basic truths. While the anti-vaxxers and climate change deniers seem to support the Republican party more often than the Democrats, such issues affect all of us and the March for Science will not achieve its goals by displaying partisanship. Alienation is not what we need right now, but rather, we need to be able to win over the other side. 

Just a quick note – the March for Science is taking place on Earth Day, April 22. So PLEASE MAKE SURE you take your signs with you after the march, or recycle them and if you would like, help with clean-up afterwards. This is also our responsibility, not only as scientists, but also as members of society taking part in a civic and political action. 

Hope to see you all at the March, with your awesome signs.

For Science, In Solidarity!

CMDB and Genetics Programs Come Together in Portland, Maine

For the first time, the Genetics and CMDB programs came together for a retreat in Portland, Maine for the snow and slush-filled weekend of April 1st. The retreat brought together students from different programs to interact and learn more about one another’s’ research, as well as students from different campuses. Both the Boston and the Bar Harbor Jackson Laboratories contingents made it to Portland to join the Scarborough Maine Medical Research Center Institute (MMCRI) folks for a weekend of science and camaraderie. Students and faculty gave brief talks on their work, followed by a poster session and a fantastic keynote speech on storytelling was given by Christine Gentry. Read on for details on the weekend, written by Jessica Elman (CMDB, Boston Campus), Jessica Davis-Knowlton (CMDB, MMCRI), and Alexander Fine (Genetics, JAX).  

We kicked off the retreat with a marathon of 16 talks given by students in year four and up from the CMDB and Genetics programs. Given the challenge to present a summary of their work in seven minutes or less, the students delivered with presentations that were brief but pointed. Three winners were selected by Philip HInds, Ira Herman, and Rajendra Kumar-Singh for their exceptional clarity, creativity, and concision.

In third place, Melissa LaBonty, a 5th year CMDB student in Pamela Yelick’s lab, presented on her work studying Fibrodysplasia Ossificans Progressiva (FOP). In this rare and severely understudied disease, an abnormal wound repair mechanism results in bone ossification in soft tissue after damage or injury. LaBonty is working with zebrafish to create a model of FOP, which will help to better characterize the disease and understand the underlying mechanisms that drive its progression. In her presentation, LaBonty spoke clearly and at an even pace, with assisting powerpoint slides that displayed only the most essential words: together this style helped keep the group focused on her story and contributed to her ranking as one of the best speakers of the day.

 

Siobhan McRee, a 5th year Genetics student in Philip Hinds’ lab, came in second among the student presenters. McRee talked about her work in which she is elucidating the roles of different Akt isoforms in BRAF-mutant melanoma. Though this cancer is initially responsive to the drug Vemurafenib, which specifically targets cells with a BRAF-mutation, cells with other driving mutations manage to survive the drug treatment and clonally expand, resulting in significant and potentially deathly relapse of disease. Ultimately, McRee’s work will help to better understand how the Akt signaling pathway is involved in this disease and may result in more therapeutically targetable molecules. McRee’s story logically built from general facts and understanding of BRAF melanoma to ultimately culminate on more specific data showing her findings thus far as well as their implications. Furthermore, her even pace and well-organized slides made her an especially great presenter that day.

Coming in first place was Kayla Gross, a 4th year CMDB student in Charlotte Kuperwasser’s lab. Gross’s work involves understanding how aging contributes to the breast cancer development, and why certain subtypes of breast cancer are more prevalent in the aging population. Given the prevalence of breast cancer, the impactfulness of Gross’ research is immediately obvious. She worked with an aging mouse model to characterize their mammary tissue as well as performed an RNAseq experiment to uncover molecular mechanisms that might be differentially expressed in young and aging mouse tissue. Gross presented her data in a logical progression, and used illustrative cartoons and animations to her advantage to keep her audience focused and to get her point across. Besides for her brilliant and captivating powerpoint, Gross stood out for her speaking style: she had clearly chosen her words to be concise and to the point, which allowed her to make the most of the seven minutes allotted to her.

All in all, the student presentations were remarkably impressive: in just seven minutes, all the participating students managed to convey the most critical and interesting components of their research. This was a great opportunity for everyone to learn a little bit more about what our colleagues are working on, as well as a chance to practice our “flash talk” skills, which will come in handy whether it’s at a job interview or at Thanksgiving table when your uncle asks you to explain what you’re doing in graduate school for the third time.

The Story Collider’s Christine Gentry, PhD as keynote

It was suggested by Terry Pratchett, Ian Stewart, and Jack Cohen in The Science of Discworld II: The Globe that perhaps Homo sapiens as a name for our species is a bit of a misnomer considering we are not omnipotent beings. They suggest Pan narrans, the storytelling ape, because we gain understanding by fitting facts into a larger narrative rather than collecting and storing millions of pieces of disparate information.

As communicators of new knowledge to the world (i.e. our scientific findings), it is important for us to keep the nature of our listeners in mind. In her keynote presentation to the retreat, Story Collider’s Christine Gentry, PhD encouraged us all to think about how to frame our narratives to be more approachable and demonstrated some methods of drawing in an audience.

She immediately captured our attention and sympathy by describing the challenges she faced in a wending career path that started with her geek excitement to bring a black widow spider to her Texas elementary school show-n’-tell, traversed through public outreach on the topic of zoology, and has landed at teacher/storyteller in Boston.

She required us to engage with her material by highlighting snippets of stories that we examined in small groups to find the element that made them compelling. We saw that admitting to vulnerability helps to humanize us to our audience in the story from a researcher who relies on fresh donor tissue, that self identity makes us more honest in the story from a researcher who decided not to cover her tattoos, and that we can surprise our audience by not sticking to script in the story from David who refused to tell the inspiration arising from conflict story that reporters sought to box him into. The thread tying all these stories together is that at the core they are about relationships with others, ourselves, our work, and with the larger community.

Perhaps the most memorable take-home point from her talk is that anecdotes do not equal stories. The response to most anecdotes is naturally “so what?” In order for an event or experience to be a story, it must have changed you: “I was callus, this event happened, and now I am more thoughtful” rather than “I am amazing, I did this, and I am still amazing!”

Scientific inquiry must be done in an objective manner and it is imperative that we remain unbiased as possible when we review scientific evidence, but there is room for us to inject our personalities into our presentations and relate our findings to the people who care. Now it remains to us to decide when to do so and to what degree.

On Sunday morning, we took a break from data and lectures; it was time to start working together. The purpose of this retreat was cross-program cooperation, and in our final event of the weekend, we put that goal into action. We separated into breakout sessions, not by program or campus, but by what we are interested in. These small group discussions were designed to get people together with various strengths and experiences to think about how to solve some of the challenges that graduate students face.

So what are graduate students at Sackler interested in discussing? The topics of these breakout sessions varied. Some sessions focused on day-to-day problems that a graduate student might face, like using CRISPR/Cas9 or selecting a sequencing platform. In the CRISPR discussion, participants came to the conclusion that there are no specific shared standards for all the applications of CRISPR and identified strategies to address potential off-target effects.

Other discussions centered on how to accomplish broader training goals, including grant writing, mentoring, and communicating in science. The grant writing section reviewed general writing strategies, like setting short-term, realistic goals, and shared a need for a formalized grant-writing course at Sackler. The mentoring/leadership session discussed existing programs at Sackler where a student can find a mentor, like the Tufts Mentoring Circles and the Tufts Biomedical Business Club. Students expressed a need for a more accessible alumni network, including cross-institutional resources. In the scientific communication group, students were urged to get on social media platforms like LinkedIn, Twitter, and ResearchGate.

In two of the largest breakout sessions, participants concentrated on solving larger scale problems: designing coursework for a modern graduate program in biology and bridging the gap between science and medicine. To help bridge the gap between scientific research and medicine at Tufts, the discussion group recommended that faculty members be identified that can connect labs with clinicians and tissue banks. In addition, access to a course that provides a basic orientation to clinical research would benefit many students at Sackler. In the session on coursework for a modern graduate program, one topic became the clear center of the discussion: computational biology! Whether students had struggled through teaching themselves or were currently stuck with a dataset they didn’t know how to analyze, everyone in the room agreed that coursework in computational biology was crucial for a graduate student’s success in modern biology. In addition to new coursework, students from both programs expressed a need for a revision and update of their first year coursework.

While all of the breakout sessions at the retreat were productive, they are meant to be starting points for continued discussion and collaboration. This retreat should be the springboard that leads to action across programs and institutions. Sackler students are lucky to be in programs that span multiple states, campuses, and research focuses. The cross talk between these groups will make each of our programs stronger and better prepare us for our careers in the future.

GSC COMMITTEE & CLUB UPDATES: MARCH 2016

GSC Career Paths Committee

On February 13, 2017, the GSC Career Path’s Committee kicked off the year with a workshop learning the basics of the Prism Graphpad software. In the past, students had expressed interest in analysis of data using statistical software as well as graphing the data in a presentable fashion. Therefore, the GSC thought a workshop on PRISM would not only be very useful but also have a significant impact on the students’ research careers. The workshop was kindly guided by Dr. Dan Cox, a professor in the Neuroscience department, and it took place in the computer room in the Sackler library. The workshop was well-received, according to GSC representatives Vaughn Youngblood and Roaya Alqurashi. “(The workshop) was a successful one. The attendees loved how Dr. Cox explained each application you will need to use in Prism with an active learning experience” Roaya said. Vaughn mentioned “the Prism workshop was helpful!  It taught the fundamentals of using Prism along with how to represent different types of data.  Hopefully, we can bring Dr. Cox in for another session with another statistical program like R.” If time permits this year, the GSC Career Path’s Committee hopes to hold several more workshops like this with different analysis softwares (R, SAS, etc.).

ICYMI: Public Relations and Communications Essentials for Scientists

When it comes to reporting our scientific findings, we are trained to compose manuscripts that are measured, precise and objective. The mainstream media, however, take a very different approach to broadcasting scientific news: headlines designed to grab readers tend to be more sensationalized and the articles draw more conclusive and overarching statements. These contrasting approaches to reporting are appropriate in their respective fields and it is important that we as scientists learn to take advantage of mainstream journalism for the publication of our discoveries, not only for the reputations of our university and ourselves, but also to share with the public, whose tax dollars fund most of our work, what we have accomplished. Enter the Tufts Public Relations Office—a fantastic resource that allows us the opportunity to share our research with the community outside of our scientific world. The purpose of the seminar du jour was to inform the Tufts community on how the office works and how to best use it to our advantage.

The purpose of the seminar was to provide some information on how to work with the PR office when you are ready to publish work that you would like to broadcast beyond scientific journals. Kevin, the assistant director of the office, stressed that the earlier you get in touch with the PR office, the better prepared they will be to help you. The best time to contact them about publicizing a manuscript is when you are submitting your final revisions to the scientific journal that will be publishing the paper. You will be asked to share your manuscript with the office so that Kevin and members of his team, who are well versed in reading scientific literature, can familiarize themselves with your work. Soon after, they will meet with you to discuss the details of your study, get a quote, and draft a news release that your PI can edit and approve. From there on out, the PR Office works to spread the word on your research via prominent blogs, science, local, and potentially national media, depending on your work’s level of impact. The PR Office is also equipped to help you interact with reporters effectively: they can prepare you to talk about your science in layman’s terms to be more relatable and better understood by the general public.

By sharing your work with more mainstream media, you build your reputation as well as credit your university, your funding agencies, and the tax-paying public. Reach out to the PR Office for more information on communicating your science with the rest of the world and take advantage of the great opportunities they offer that can make you a more visible and effective participant in the science world!

One last tip for those of you interested in improving your science communication skills–keep your eyes peeled for more details on our upcoming joint Dean’s Office / TBBC / GSC Event, Sackler Speaks in April!  This is a competition for students to pitch their 3-minute flash talks in front of a panel of judges.  Besides critical feedback on presentation skills, there will also be cash prizes for winning presentations!

Contacts at the Tufts PR Office, Boston Campus:

Siobhan Gallagher, Deputy Director (Siobhan.gallagher@tufts.edu)

Kevin Jiang, Assistant Director (Kevin.Jiang@tufts.edu)

Lisa Lapoint, Assistant Director (Lisa.Lapoint@tufts.edu)

 

Reflections from AAAS 2017 – Research During the Trump Administration

The theme of this year’s American Association for the Advancement of Science (AAAS) meeting in Boston was “Serving Society through Science Policy.” As we move through the first few months of a new administration, this gathering could not have been more timely. While this conference is diverse with topics ranging from gene editing to criminology, the undercurrent of the meeting was anxiety over what will happen to research under the Trump administration.

What is science policy even? Most in this audience probably think of it as how much money research gets budgeted and occasional rule changes on whether fetal stem cell research can occur. Generally, science policy is the set of federal rules and policies that guide how research is done. Science policy can be split into two general frameworks: policy for science and science for policy. These can often feed into each other. For example, policy for science provides funds for climate research. The data and conclusions derived from that research could then inform new climate related policies. That would be science for policy. While science itself is an important input into the whole process, other considerations such as economics, ethics, budgets and public opinion are also inputs. As a scientist who considers science as a method of interpreting the world, my biases had not let me consider non-science inputs for science policy decision-making. It may seem obvious to some, but it was illuminating to realize that other concerns can be just as valuable and legitimate.

As funding is a major reason scientists are concerned, I was happy to learn a lot about the place of research in the federal budget. There are some out there who believe that research in Boston will be fine no matter who is in charge because of all the industry science in the area. It’s true; around two-thirds of research and development is funded by industry. However, industry is mostly concerned with development. Basic research is primarily funded by federal money. The federal budget is divided into mandatory spending and discretionary spending. Mandatory spending does not require congress to act for programs in it to be funded. These include the entitlement programs such as Social Security, Medicare and Medicaid. Dr. Josh Shiode, a Senior Government Relations Officer from AAAS, informed us that entitlement programs are considered “third-rail” discussions by lawmakers, meaning if you touch them, you die (an electoral death). In contrast, discretionary spending requires Congress to actively fund. Most of research and development spending falls into this category.

 

 

Due to changing (aging) demographics, the percentage of the budget that goes towards mandatory spending has been steadily increasing. 50 years ago, we spent around 30% of the federal budget on mandatory spending and now we are up to 70% and increasing. Research and development generally gets around 10-12% of the remaining budget left for discretionary spending. Traditionally, increases in discretionary defense spending will correspond with a parallel increase in nondefense discretionary spending. The Trump administration has proposed increases in military spending. Given likely tax cuts and reluctance to make changes to entitlement programs, it is unlikely nondefense discretionary funding will fare well. The good news is major research programs like the BRAIN Initiative, Precision Medicine Initiative and the Cancer Moonshot were funded through the bipartisan 21st Century Cures act during the lame-duck session. While NIH and biomedical research will likely have diminished profiles during this administration, both parties are against Alzheimer’s, diabetes and cancer. What is less clear is how research performed by the EPA and Department of Agriculture will fare although initial reports are grim. Finally, repeal of the Affordable Care Act will have rippling effects, as many research universities are also providers of healthcare. It is clear that there will be a shift in culture. Under President Obama, science was elevated and scientists were regularly consulted. As former senior science adviser to President Obama John Holdren said: “Trump resists facts he doesn’t like”.

There is reluctance for some scientists to get involved in the political theater, as some believe science should be apolitical. I would argue that science is already political as science can dictate policy and policy can dictate science. What science is and should be is nonpartisan. No party has an inherent monopoly on being allies of science and scientific thinking. So what can scientists do? All politics is local and personal. The majority of Americans say they don’t know a scientist. This is an easy thing to work on. Make sure you introduce yourself to others! Visit your lawmakers and let them know that you are funded by federal money. Politicians are most concerned about their own districts and so if you’re a transplant, you likely have connections to more than one district. Try to build a relationship with him or her by seeing if you could help with anything. Figure out if you can help your local community with anything by serving on committees. Speaking of committees, know what committees your representatives are on. When communicating, think carefully about what words you use. Former U.S. Congressman Bart Gordon opined that he never called it climate  change. Instead, he called it energy independence. While branding may sound like a trivial thing to worry about, targeted story telling is extremely important. We would love for our data to speak for itself but people connect best to stories, especially ones concerning things they can relate to or care about.

If you’re interested in science policy, there are a number of good resources available to get better acquainted. The Engaging Scientists & Engineers in Policy (ESEP) Coalition has a wealth of information and resources on their website (http://science-engage.org/). In fact, they host a local monthly science policy happy hour to network and engage those interested in science policy. If you are interested in learning more about the R&D budget, AAAS has an excellent resource with analyses of federal research and development funding (https://www.aaas.org/program/rd-budget-and-policy-program). There you can also find their data dashboard to look at funding for specific agencies for different periods of time.